Potential of Mw as a prophylactic vaccine against pulmonary tuberculosis

Vaccine

Volumn 26, Issue 9, 2008, Pages 1228-1234

  Katoch, K ^a   Singh, Padam ^b   Adhikari, T ^c   Benara, S K ^c   Singh, H B ^a   Chauhan, D S ^a   Sharma, V D ^a   Lavania, M ^a   Sachan, A S ^d   Katoch, V M ^a  

^a NATIONAL JALMA INSTITUTE FOR LEPROSY AND OTHER MYCOBACTERIAL DISEASES   (India)

^b Research and Evaluation   (India)

^c INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^d S N MEDICAL COLLEGE   (India)

Author keywords

Immunoprophylaxis; Mycobacterium w; Tuberculosis

Indexed keywords

MYCOBACTERIUM VACCINE; MYCOBACTERIUM W VACCINE; PLACEBO; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; HUMAN; IMMUNOPROPHYLAXIS; INCIDENCE; INDIA; LEPROSY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; SPUTUM SMEAR; STATISTICAL ANALYSIS; VOLUNTEER;

BACTERIAL VACCINES; DOUBLE-BLIND METHOD; HUMANS; INCIDENCE; INDIA; LEPROSY; MYCOBACTERIUM; PREVALENCE; RURAL POPULATION; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; VACCINATION;

EID: 39149098806     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.12.025     Document Type: Article

References (31)

1. Katoch V.M. A report on the biochemical analysis of Mycobacaterium w. Lepr India 53 (1981) 385-388
2. Talwar G.P. Vaccines in leprosy. Lepr India 55 (1983) 8-11
3. Yadava A., and Mukherjee R. An immunodominant 30-kDa antigen of a candidate anti-leprosy vaccine Mycobacterium w, shares T and B cell determinants with M. leprae and M. tuberculosis. Med Microbiol Immunol 5 (1993) 243-253
4. Katoch K., Katoch V.M., Natrajan M., Bhatia A.S., Sreevatsa, Gupta U.D., et al. Treatment of bacilliferous BL/LL cases with combined chemotherapy and immunotherapy. Int J Lepr 63 (1995) 202-212
5. Katoch K., Katoch V.M., Natrajan M., Sreevatsa, Gupta U.D., Sharma V.D., et al. 10-12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy. Vaccine 22 (2004) 3649-3657
6. Zaheer S.A., Mukherjee R., Ramkumar B., Misra R.S., Sharma A.K., Kar H.K., et al. Combined multidrug and Mycobacterium w vaccine therapy in patients with multibacillary leprosy. J Infect Dis 167 (1993) 401-410
7. Sharma P., Misra R.S., Kar H.K., Mukherjee A., Poricha D., Kaur H., et al. Mycobacterium w vaccine a useful adjunct to multidrug therapy in multibacillary leprosy. A report on hospital based immunotherapeutic trial with a follow-up of 1 to 7 years after treatment. Lepr Rev 71 (2000) 170-193
8. Sarkar A.D., Kaur I., Radotra B.D., and Kumar B. Impact of combined Mycobacterium w vaccine and 1 year of MDT on multibacillary leprosy patients. Int J Lepr Other Mycobact Dis 60 (2001) 187-194
9. Patel N., Deshpande M.M., and Shah M. Effect of immunomodulator containing Mycobacterium w on sputum conversion in pulmonary tuberculosis. J Indian Med Assoc 100 (2002) 191-193
10. Patel N., and Tripathy S.B. Improved cure rates in pulmonary tuberculosis Category II (retreatment) with Mycobacterium w. J Indian Med Assoc 101 (2003) 680-682
11. Guleria I., Mukherjee R., and Kaufmann S.H. In vivo depletion of CD4 and CD8 T lymphocytes impairs Mycobacterium w vaccine induced protection against M. tuberculosis in mice. Microbiol Immunol 182 (1993) 129-135
12. Singh I.G., Mukherjee R., and Talwar G.P. Resistance to intravenous inoculation of Mycobacterium tuberculosis H37Rv in mice of different inbred strains following immunization with a leprosy vaccine based on Mycobacterium w. Vaccine 9 (1991) 10-14
13. Sharma P., Mukherjee R., Talwar G.P., Sharatchandra K.G., Walia R., Parida S.K., et al. Immunoprophylactic effect of anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow-up of 8-10 years. Lepr Rev 76 (2005) 127-143
14. Stein S.C., and Aronson J.D. The occurrence of pulmonary lesions in BCG vaccinated and unvaccinated persons. Am Rev Tuberc 68 (1953) 695-712
15. Rosenthal S.R., Loewinsohn E., Graham M.L., Leveright D., Thorne M.G., and Johnson V. BCG vaccination against tuberculosis in Chicago. A twenty year study statistically analysed. Paediatrics 28 (1961) 622-641
16. British Medical Research Council. BCG and Vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Bull WHO 46 (1972) 371-385
17. Palmer C.E., Shaw L.W., and Comestock G.W. Community trials of BCG vaccination. Am Rev Tuberc 77 (1958) 877-907
18. Frimodt-Moller J., Acharyalulu G.S., and Parthasarthy R. Observations on the protective effect of BCG vaccination in South India rural population. Indian J Tuburc 15 (1968) 40-44
19. Tuberculosis Prevention Trial, Madras. Trial of BCG vaccines in South India for tuberculosis prevention. Indian J Med Res 70 (1979) 349-363
20. Comstock G.W., and Palmer C.E. Long term effects of BCG vaccination in southern United States. Am Rev Respir Dis 93 (1966) 171-183
21. Bailey G.V.J. Present status of immunization against tuberculosis. Indian J Tuburc 28 (1981) 117-125
22. Colditz G.A., Berkey C.S., Mosteller F., Brewer T.F., Wilson M.E., Burdick E., et al. The efficacy of bacillus Calmette Guerin vaccination in newborns and infants in the prevention of tuberculosis: meta analyses of the published literature. Paediatrics 96 (1995) 29-35
23. Randomized controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group. Lancet 1996;348:17-24.
24. Dietrich G., Viret J.F., and Hess J. Novel vaccination strategies based on recombinant Mycobacterium bovis BCG. Int J Med Microbiol 292 (2003) 441-451
25. Ginsberg A.M. What is new in tuberculosis vaccine?. Bull WHO 80 (2002) 1-14
26. Horwitz M.A., and Harth G. A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in guinea pig model of pulmonary tuberculosis. Infect Immun 71 (2003) 1672-1679
27. Singh I.G., Mukherjee R., Talwar G.P., and Kaufmann S.H. The in-vitro characterization of T cells from Mycobacterium w vaccinated mice. Infect Immun 60 (1992) 257-263
28. Reddi P.P., Amin A.G., Khandekar P.S., and Talwar G.P. Molecular definition of a unique species status of Mycobacterium w, a candidate leprosy vaccine strain. Int J Lepr 62 (1994) 229-236
29. Fine P.E. BCG: the challenge continues. Scand J Infect Dis 33 (2001) 243-245
30. Stanford L.J. Immunotherapy with Mycobacterium vaccae for pulmonary tuberculosis. Phil J Microbiol Infect Dis 21 (1992) 73-75
31. Johnson J.L., Kamyan R.M., Okera A., Loughin A.M., Nyole S., Honn D.L., et al. Randomized control trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus infected Ugandan adults with newly diagnosed pulmonary tuberculosis. The Uganda Case Western Reserve University Research Collaboration. J Infect Dis 181 (2000) 1304-1312